| |
|
|
|
Cellect Biotechnology Ltd.  
|
|
2.74 -0.02 (-0.01%) |
01-15 16:00 |
|
Open: |
2.68 |
Pre close: |
2.76 |
Target:
|
3.68
|
|
High: |
2.7707 |
Low: |
2.62 |
Resistance:
|
3.15
3.68
|
|
Volume: |
92,454 |
Market Cap: |
11M |
Support:
|
2.51
2.11
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.69
 |
MACD |
MACD(12,26):
|
0.14  |
|
MA(20): |
2.43 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
2.15 |
Stochastic Oscillator |
%K(14,3):
|
81.63 |
|
MA(250): |
2.44 |
%D(3): |
77.55 |
|
Average Volume(K) |
3-Month: |
27577
|
52-Week |
High:
|
5.40 |
|
10-Days: |
14779 |
Low: |
0.40 |
|
RSI |
RSI(14):
|
66.02 |
Change(%): |
-2.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.854 |
Return on Equity (ttm) |
-99.6 |
Shares Out. (M) |
3.91 |
|
EPS Est. Current Year |
-1.560 |
Return on Assets (ttm) |
-38.0 |
Shares Float (M) |
2.72 |
|
EPS Est. Next Year |
-1.350 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.03 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
27.15 |
|
Forward EPS |
-0.206 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
123 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.21 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
